RSLS logo

ReShape Lifesciences (RSLS) Company Overview

Profile

Full Name:

ReShape Lifesciences Inc.

Sector:

Healthcare

Country:

United States

IPO:

October 6, 2016

Indexes:

Not included

Description:

ReShape Lifesciences is a medical technology company focused on weight loss solutions. They develop innovative products, including gastric balloons and other devices, to help people manage obesity and improve their health. Their goal is to provide effective, minimally invasive options for long-term weight management.

Key Details

Price

$1.08

Annual Revenue

$8.68 M(-22.79% YoY)

Annual EPS

-$110.78(+98.25% YoY)

Annual ROE

-220.59%

Beta

0.26

Events Calendar

Earnings

Next earnings date:

Apr 1, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Apr 1, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 23, 2024

Analyst ratings

Recent major analysts updates

Jul 17, 24 Maxim Group
Hold
May 26, 22 Alliance Global Partners
Buy
Oct 8, 21 Maxim Group
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for ReShape Lifesciences?
  • Does ReShape Lifesciences pay dividends?
  • What sector is ReShape Lifesciences in?
  • What industry is ReShape Lifesciences in?
  • What country is ReShape Lifesciences based in?
  • When did ReShape Lifesciences go public?
  • Is ReShape Lifesciences in the S&P 500?
  • Is ReShape Lifesciences in the NASDAQ 100?
  • Is ReShape Lifesciences in the Dow Jones?
  • When was ReShape Lifesciences's last earnings report?
  • When does ReShape Lifesciences report earnings?
  • Should I buy ReShape Lifesciences stock now?

What is the ticker symbol for ReShape Lifesciences?

The ticker symbol for ReShape Lifesciences is NASDAQ:RSLS

Does ReShape Lifesciences pay dividends?

No, ReShape Lifesciences does not pay dividends

What sector is ReShape Lifesciences in?

ReShape Lifesciences is in the Healthcare sector

What industry is ReShape Lifesciences in?

ReShape Lifesciences is in the Medical Devices industry

What country is ReShape Lifesciences based in?

ReShape Lifesciences is headquartered in United States

When did ReShape Lifesciences go public?

ReShape Lifesciences's initial public offering (IPO) was on October 6, 2016

Is ReShape Lifesciences in the S&P 500?

No, ReShape Lifesciences is not included in the S&P 500 index

Is ReShape Lifesciences in the NASDAQ 100?

No, ReShape Lifesciences is not included in the NASDAQ 100 index

Is ReShape Lifesciences in the Dow Jones?

No, ReShape Lifesciences is not included in the Dow Jones index

When was ReShape Lifesciences's last earnings report?

ReShape Lifesciences's most recent earnings report was on Nov 14, 2024

When does ReShape Lifesciences report earnings?

The next expected earnings date for ReShape Lifesciences is Apr 1, 2025

Should I buy ReShape Lifesciences stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions